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Consequences of COVID-19 crisis for
persons with HIV: the impact of social
determinants of health
Kristie C. Waterfield1, Gulzar H. Shah2* , Gina D. Etheredge3 and Osaremhen Ikhile1

Abstract
Background: With the indiscriminate spread of COVID-19 globally, many populations are experiencing negative
consequences such as job loss, food insecurity, and inability to manage existing medical conditions and maintain
preventive measures such as social distancing and personal preventative equipment. Some of the most
disadvantaged in the COVID-19 era are people living with HIV/AIDS and other autoimmune diseases.
Discussion: As the number of new HIV infections decrease globally, many subpopulations remain at high risk of
infection due to lack of or limited access to prevention services, as well as clinical care and treatment. For persons
living with HIV or at higher risk of contracting HIV, including persons who inject drugs or men that have sex with
men, the risk of COVID-19 infection increases if they have certain comorbidities, are older than 60 years of age, and
are homeless, orphaned, or vulnerable children. The risk of COVID-19 is also more significant for those that live in
Low- and Middle-Income Countries, rural, and/or poverty-stricken areas. An additional concern for those living the
HIV is the double stigma that may arise if they also test positive for COVID-19. As public health and health care
workers try to tackle the needs of the populations that they serve, they are beginning to realize the need for a
change in the infrastructure that will include more efficient partnerships between public health, health care, and
HIV programs.
Conclusion: Persons living with HIV that also have other underlying comorbidities are a great disadvantage from
the negative consequences of COVID-19. For those that may test positive for both HIV and COVID-19, the increased
psychosocial burdens stemming from stress and isolation, as well as, experiencing additional barriers that inhibit
access to care, may cause them to become more disenfranchised. Thus, it becomes very important during the
current pandemic for these challenges and barriers to be addressed so that these persons living with HIV can
maintain continuity of care, as well as, their social and mental support systems.
Keywords: HIV, COVID-19, Public health, Comorbidities, Consequences

Background
The transmission of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel virus that
causes COVID-19 infection, seems to be indiscriminate.
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The negative consequences of COVID-19 for some populations are more severe than others, including job loss,
food insecurity, inability to manage existing conditions,
and inability to maintain preventive measures such as
social distancing and use of personal protective equipment (PPE). Those who live in poverty have less control
of their living arrangements and their immediate environment, thus the barriers that they are facing when trying to protect themselves and their families are greater
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than those that are not living in poverty [1, 2]. Among
the most disenfranchised and most disadvantaged in the
COVID-19 era are people living with HIV/AIDS, people
at risk of contracting HIV such as sex workers, people
who inject drugs, and men who have sex with men, and
people with other autoimmune diseases [3]. As the pandemic has led to significant changes in health service delivery and amplified fears of increased death and illness,
the health inequities and the consequences of these
changes among various subgroups of those living in
HIV/AIDS, or at risk of contracting HIV must be
reviewed through the lens of social determinants of
health (SDoH).

Main text
Cross-cutting circles of disadvantages and health inequity
for PLHIV

As the number of new HIV infections decrease globally,
there are still subpopulations that remain at higher risk
of infection and have limited or no access to prevention,
care, and treatment. The populations that are the hardest hit are those that also lack power and experience
high levels of food insecurity, poverty, drug abuse, incarceration among men, and those suffering from other infectious and chronic diseases [4, 5].
Disadvantages for PLHIV with other underlying
comorbidities

For persons living with HIV (PLHIV) and persons at risk
for contracting HIV, many SDoH will change for the
worse during the COVID-19. The PLHIV, especially
people of color and with additional underlying conditions, have an elevated risk of SARS-CoV-2 infection.
There is emerging empirical evidence that the risk of
SARS-CoV-2 transmission and COVID-19 deaths is
higher for immunocompromised persons, people of
color (especially those of African descent), or those with
certain pre-existing conditions such as cancer, hypertension, heart disease, lung disease, and diabetes [6]. According to the Centers for Disease Control and
Prevention (CDC), 16.7% of COVID-19 patients in intensive care are immunocompromised with underlying
health conditions [4] and their chances of recovery are
much lower. People of color, especially those of African
descent, and those living in resource-poor countries are
significantly more likely to experience access to care barriers and mortality related to COVID-19 [1, 2]. PLHIV
with other underlying comorbidities (e.g., diabetes, cardiovascular disease, lung disease) are at an even greater
disadvantage than PLHIV without additional underlying
comorbidities [6]. Before the advent of effective combination antiretroviral therapy (ART), advanced HIV infection was a risk factor for complications of other
respiratory infections, and severe respiratory distress [7].
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COVID-19 increases the likelihood of a syndemic effect
on PLHIV with underlying comorbidities. For example,
research has shown that HIV/TB co-infection not only
augments the immunopathology of HIV and accelerates
the damaging progression of the disease; but that ART
initiation must be timed in order to increase adherence
and decrease adverse effects of drug interactions [8] especially for those utilizing HIV clinics in Low- and
Middle-Income Countries (LMIC).
The social support and community mobilization approaches for the management of HIV/AIDS, as opposed
to individual-level approaches alone, have been shown to
improve antiviral medication adherence [9]. However,
due to the enforcement of social distancing and other
restrictions in the current pandemic, there has been a
shift in the mechanism by which PLHIV receive such social support. A breakdown in social support would likely
impact medication adherence as individuals with a low
CD4 cell count and PLHIV not on ART are at a higher
risk of becoming extremely sick with COVID-19 infection [6]. It is imperative to explore and monitor the adequacy of the current guidelines for the management of
PLHIV with other underlying comorbidities. However,
ensuring PLHIV have access to their antiviral refills, as
well as the maintenance of their social support including
material and mental support from community, family,
and friends [9] may pose a challenge; hence, the need for
the establishment of proper linkage to care. Additionally,
PLHIV in LMIC and rural areas may experience additional barriers that inhibit access to care such as the
lack of adequate technology for telemedicine, lack of
transportation to open clinics, and additional costs and
complexity required to provide care during the current
pandemic.
Double-jeopardy for COVID-HIV social stigma

Shiau and colleagues (2020) note that PLHIV not only
faces a higher risk of severe illness from COVID-19 infection due to compromised immune systems, they also
have increased psychosocial burdens emanating from
stress and isolation [10]. The compounded stigma associated with HIV-positive status and SARS-CoV-2 may
lead to an array of mental health issues comprising psychological disorders such as stress, depression, sleep disorder, substance abuse, anxiety, schizophrenia, and
personality disorders, which may trigger somatoform
disorders. Instances of blatant wrongful attributions of
certain race categories as a source of SARS-CoV-2
spread inflicts additional harm [11]. The compounded
HIV/COVID-19 stigma may lead to failure to seek care.
The suffering and social stigma are worse for disenfranchised and low socioeconomic status (SES) individuals
and subgroups, creating health disparities. COVID-19related cancellations of patient procedures and the non-
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availability of doctors will make the systems too overburdened to care for these groups [12]. The suffering
and social stigma are worse for disenfranchised and low
SES individuals and subgroups, creating health inequities
and disparities. A recent study suggests that the intersection of social stigma and other social and economic disadvantages among marginalized people, particularly in
under-resourced communities, face health disparities in
COVID-19 prevention and treatment. Those health disparities stem from a lack of access to care and the inability to practice recommended preventive practices as
proper social distancing [13]. An inclination to escape
social stigma by suppressing information about SARSCoV-2 positive persons’ contacts with others is a significant barrier to preventive services such as contact tracing and recommended regular reporting of compliance
concerning compliance among persons in quarantine.
Elevated COVID-19 risk for older adults with HIV or at risk
for HIV

According to the CDC and World Health Organization,
the prevalence rate among confirmed COVID-19 cases
in older adults is approximately 31%, and the death rates
from COVID-19 increase with age (60–69 years old
3.6%, 70–79 years old 8.0%, and 80+ years old 18.8%)
[14]. Since the identification of SARS-CoV-2 in December 2019, the most common comorbidities among
COVID-19 patients with the highest mortality rates (6.0
to 10.5%) and worst health outcomes are cardiovascular
disease, chronic respiratory disease, obesity, and diabetes
[15]. Even though older adults living with HIV or at risk
for HIV make up a small portion of the overall global
population, they represent the segment of the population
that is at greater risk of having these comorbidities due
to changes in their bodies as they get older as well as the
effects of an unhealthy lifestyle and/or heredity. So,
while the overall projected case fatality rate (CFR) for all
confirmed cases has decreased since February 2020, the
CFR for older adults has stayed relatively the same and
for those over the age of 80 has increased [16].
COVID-19 risk for orphans and vulnerable children in
LMIC

Individuals dependent on other people for care and support, and individuals without self-autonomy, are among
the most vulnerable persons around the world. Orphans
and Vulnerable Children (OVC) in Low- and MiddleIncome Countries comprise a subset of these, with the
added burden of having lost one or both parents to HIV
and being infected or affected by HIV (USG PEPFAR
definition). If OVC cannot live with their biological parents, they often live with extended family members, in
families that experience greater physical/economic/
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psychosocial hardships than others, on the street, or in
group homes.
Even before the COVID-19 pandemic, OVC in LMIC
were known to perform less well in school and be more
likely to lag in grade-for-age, suffer from more abuse, experience higher rates of unwanted pregnancies, and have
less medical attention than non-OVC. OVC depend on
their caregivers, some of whom have HIV themselves. In
many countries, HIV programs have been sharply affected, with care and treatment clinic hours being reduced, medical personnel re-deployed from HIV services
to COVID-19 services, community health workers’
movement restricted such that they are unable to do
mobile outreach or home visits, supply chains disrupted,
etc. In the medical field and other associated sectors,
these structural changes, coupled with population movement restrictions or total lockdowns, food, and other
commodities’ scarcities, unemployment, and social unrest, contribute to a hotbed of tension, anxiety, and
sometimes, most unfortunately, desperation.
Incidences of interpersonal violence (IPV) are on the
rise. IPV victims are usually those without power; children
are likely victims. Without the means to fight back, including the emotional or cognitive maturity to understand
their rights, they too often fall into a cycle of abuse. OVC
is dependent on others. They need the structure of a caring and enabling environment, and if they have HIV, enrollment in treatment, and access to antiretroviral therapy
and viral load testing. Peer support groups for HIVpositive individuals have been demonstrated to increase
coping mechanisms and increase adherence. Support
groups, where population movement has been restructured, are no longer feasible. OVC may suffer the most because of the doubly fragile lives -- being a single or
double-orphan, and infected or affected by HIV. When
the lives of a population are severely disrupted and threatened, the most vulnerable suffer the worst.
Homelessness and unemployment among PLHIV and
those at risk for HIV

Considerable work has been done to show the impact of
homelessness on health and wellbeing. Many homeless
individuals also suffer from substance abuse, which complicates their mental status and constitutes a risky behavior for the spread of infectious disease. Homeless
shelters have been shown to increase the spread of infectious diseases such as SARS and HIV [17], thus, homeless individuals with HIV and homeless individuals that
are at risk of contracting HIV (i.e. intravenous drug
users, sex workers, and men that have sex with men) are
at a higher risk of being infected with COVID-19 [3, 17].
The synergistic effect of these poor social conditions further exacerbates the need to act, because homeless shelters are not health centers and many of them tend to
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lack the necessary resources needed to curtail the spread
of infectious diseases among those staying within the
shelters. When seeking healthcare services, those with
no access to outpatient care including homeless individuals, migrants and asylum seekers living with HIV often
resort to the emergency room; however, since the beginning of the COVID-19 pandemic, many emergency departments have had to change their procedures in order
to properly manage the influx of COVID-19 patients
and at times have had to restrict access to non-COVID19 patients (which included PLHIV and those at risk for
HIV). These changes in procedures have in turn caused
a reduction in access to care for all homeless individuals,
especially PLHIV that are in need of ART. Currently,
there are projections that the number of homeless individuals may rise due to the surge in the rate of unemployment that is related to the closure of businesses
during the COVID-19 lockdowns.
In order to curtail future transmission of COVID-19,
health and city officials need to consider the impact of
homelessness and unemployment as possible drivers of
the spread of infection. Effective communication, financial resources, food insecurity, management of chronic
diseases, respite care, personal protection, and housing
[9] are issues that should be addressed among this vulnerable population.
Other subgroups of PLHIV

Other subgroups of PLHIV, and those at risk for contracting HIV, that seem to be disproportionately affected
by the current pandemic live in LMIC, rural areas, and
high poverty/low-income areas. COVID-19 has also been
shown to affect persons of different races and ethnicities
differently due to their risk factors for certain chronic
diseases such as cardiovascular disease, chronic respiratory disease, obesity, and diabetes.
Before the current pandemic situation, many LMIC,
rural, and poverty-stricken area residents experienced
limited or no access to health care. The problem has
gotten exponentially worse due to the decrease in practitioners’ availability and increased demand for services
for active COVID-19 cases. Many clinics and hospitals
have had to change how they process and manage patients, which has in turn, caused either a cancellation or
delay in treatments for non-COVID-19 patients (including PLHIV). These COVID-19-related cancellations of
patient procedures and non-availability of doctors impact clinics and hospitals to the extent that many are
threatened with closures, ultimately imposing unemployment and financial hardships for LMIC, rural, and highpoverty/low-income communities. For those patients
that are given the option of utilizing telemedicine and
telehealth, many of them lack the necessary technology
in order to participate in these types of appointments.
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Thus, for many PLHIV, their ability to maintain their
ART regiment is proving to be an increasing challenge.
Additionally, many residents of LMIC, rural, and
poverty-stricken areas have low literacy levels, due to
their socioeconomic and educational status. A person’s
literacy level impacts their health literacy levels and their
overall health outcomes. Studies show that a person’s literacy level has a direct effect on their ability to understand health information, their knowledge of health
service availability, their decision-making capability, their
anxiety level during physician consultation, and their adherence to medications and other treatment protocols
[18]. In order for public health and healthcare to implement successful responses to infectious disease outbreaks, the population needs to be able to understand
the information that is being presented to them, follow
health instructions and guidance, and ultimately adopt
the prevention behaviors recommended. This becomes
especially important for PLHIV, people at risk for HIV,
sex workers, people who inject drugs and people with
other autoimmune diseases. Thus, COVID-19 has
brought the issue of low health literacy to the forefront,
especially during the efforts to ensure that the information can be understood by all and stop the spread of the
disease.
One of the most definitive statements that has been
made during the current pandemic is that SARS-CoV-2
does not discriminate. Unfortunately, a sobering reality
is that global trends are showing that certain racial and
ethnic groups are at higher risk of developing more severe cases of COVID-19. These populations included
those racial and ethnic groups that are at higher risk for
chronic illnesses such as high blood pressure, lung disease, kidney disease, and diabetes. When these populations reside in LMIC, rural, and poverty-stricken areas
or have low health literacy rates, their risk of being severely affected by COVID-19 increases even more.
A call for the healthcare sector to work with HIV
programs

Although it is reasonable to have repurposed health care
personnel from the HIV arena to the COVID-19 arena,
we will need these professionals, or new ones, back into
HIV. COVID-19 has taken a dramatic toll on HIV programs. Lockdowns and associated changes have hampered the ability to test new PHIV, diagnose positives,
get newly diagnosed positive persons on treatment, continue adherence to treatment (including dispensing of
antiretroviral drugs (ARVs)), and ultimately lower rates
of viral suppression. Those associated changes include
closing clinics, community health workers’ inability to
visit PLHIV, the inability of support groups to meet, and
the shortage of personal protective equipment for health
providers. Evidence already shows an overall decline in
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persons coming to facilities for HIV testing, as well as,
clinical care and treatment. Mitigation measures are in
place, including self-testing, online appointment scheduling, internet or mobile phone-based (e.g. WhatsApp)
support groups, virtual counseling, fast-tracked ARV
multi-month dispensing if it was not already the national
policy, differentiated drug delivery including home delivery, etc. Nonetheless, these measures may not be sustainable and may not be enough to close the gap in care
and treatment. Health care workers, both facility- and
community-based, will be needed now more than ever
in HIV programs.
HIV programs can learn from other sectors, and communication and sharing of lessons learned across sectors
will be critical. We cannot return to our silos. Different
sectors faced some similar challenges, but also some
unique to their field. Lessons to be learned, among
others, include the best ways to address supply chain
barriers, social behavior communication change, fearmongering and real-time rumors in the digital age, task
shifting, professionalization of para-professionals (i.e.,
the elevation of the cadre of workers with fewer skills
regarded in a more positive light, now that we realize
they are essential).
COVID-19 may have crowded out other services. Not
only were health care workers shifted to work on
COVID-19 which reduced their availability to provide
routine and even emergency care, but patients themselves put off visits to clinics or hospitals. Patients arriving at health care institutions were often sicker than
they would have been in the past due to delays (self-imposed or not) in seeking care. Careful routine data
should be examined across sectors and programs to
examine this possible crowding-out effect. Data-based
evidence will prepare us to tackle sector needs during
future public health emergencies so that we do not have
a secondary crisis once people return for care.
Need for partnerships and synergies between public
health program, healthcare and HIV programs

Public and non-profit agencies’ infrastructure for the
prevention and treatment of HIV around the globe has
matured to meet the challenges presented by HIV. Organizations constituting this infrastructure around the
globe are experienced in community partnerships,
screening and contact tracing for HIV. Resource stewardship, staff training, and leadership capacity building
for these organizations may present a cost-effective opportunity for resource-poor countries to address
COVID-19 prevention and management needs for PLHI
V. This existing infrastructure can also be strengthened
and expanded to assist with the COVID-19 crisis among
HIV-negative individuals. For instance, existing labs for
HIV testing may also be easily supported to expand their
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services for SARS-CoV-2 testing. The contact tracing
staff may be easily trained to expand their contact tracing for SARS-CoV-2 infection and train the new staff,
using their experience and best practices in confidentiality, communications, community engagement, and use
of technology. Additionally, public health partnerships
with community-based organizations can reduce the
burden of low or no access to health care services during
the current pandemic when many health care providers
are closed or providing few services. This model of use
of existing HIV prevention infrastructure to assist with
COVID-19 efforts may also be useful due to its costeffectiveness and efficiency in developed countries. For
instance, in the United States, the CDC encourages HIV
service providers to be innovative in prioritizing
COVID-19 services while still focusing their efforts on
HIV prevention and treatment [6].
Given the stigma and stress associated with HIVpositive status, any well-coordinated efforts to combat
COVID-19 will require partnerships and synergies between public health programs, healthcare providers, and
HIV programs for proper screening, and serology testing
of asymptomatic PLHIV, as well as management of persons with COVID-19 and HIV-positive statuses. These
partnerships may need to persist even when COVID crisis is over, in order to study the relative vulnerability of
PLHIV to COVID-19. Serology testing is possible, even
months or years after infection, to detect whether the
asymptomatic persons were actually infected.
Fear of the unknown, lack of specific information
about symptoms, and prevention strategies are known to
mislead the masses, resulting in challenges for programs
attempting to tackle the COVID-19. Gallup surveys in
20 countries worldwide have revealed that lack of awareness and knowledge among the masses leads people to
believe that the COVID-19 threat is not real. People
quote anecdotal evidence and social media discussions,
such as not having seen a real COVID victim. The
awareness-raising can help such people realize that Coronavirus cannot be seen, that there are a large number
of asymptomatic patients, and those with severe illness
may have been isolated and out of sight of people. Arranging for PPEs for care providers is necessary for effectiveness in contact tracing, screening, testing, and
care related to COVID-19. Even when knowledge about
SARS-CoV-2 exists, many underprivileged groups may
not comply with recommended prevention procedures
due to crowded spaces, jobs that make social distancing
impossible, and lack of PPEs. Coordinated efforts from
community stakeholders, civil society, public health
agencies, and healthcare providers may be essential for
addressing health inequities resulting from social stigma
and poor access to PPE and preventive services such as
screening and contact tracing [13].
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Conclusions
PLHIV with other underlying comorbidities (e.g., diabetes, cardiovascular disease, lung disease) are at an even
greater disadvantage and have an elevated risk of
COVID-19 infection. The negative consequences of
COVID-19 for PHIV can be more severe than for those
without HIV. The negative consequences for PHIV can
be more severe if they are elderly, OVC, or residents of
LMIC, rural, and poverty-stricken areas. Examples of
negative consequences include unemployment, food insecurity, and inability to manage pre-existing conditions
and preventive measures such as social distancing and
PPE use. The compounded stigma associated with HIVpositive status and SARS-CoV-2 may increase psychosocial burdens emanating from stress and isolation for
the disenfranchised and low SES individuals. Additionally, PLHIV that reside in LMIC and rural areas may experience additional barriers that inhibit access to care,
such as the lack of adequate technology, lack of transportation, and additional costs of care.
Globally, public and non-profit health agencies’ infrastructure has matured to meet the challenges presented
by HIV and are experienced in community partnerships,
screening, and contact tracing. Many of these agencies
have done considerable work to show the impact on the
health and wellbeing of homeless PLHIV. Unfortunately,
many of these homeless individuals also suffer from substance abuse, which can hinder their mental status and
increase the likelihood of engaging in risky behavior.
Additionally, homeless shelters have been shown to increase the spread of infectious diseases, which places
homeless PLHIV at an even greater risk of contracting
COVID-19.
During the current pandemic, PLHIV that utilize
health care institutions were often sicker than they
would have been in the past due to delays (self-imposed
or not) in seeking care. Thus, coordinated efforts from
community stakeholders, civil society, public health
agencies, and healthcare providers may be essential for
addressing health inequities for PLHIV resulting from
social stigma and poor access to PPE, preventative services and treatment. The most important challenges for
PLHIV that need to be addressed during the current
pandemic are access to their antiviral refills and maintenance of their social and mental systems; henceforward, the necessity for the establishment of proper
linkage to care and care providers.
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